Wednesday 18 November 2020
Co-chaired by Dr Maria Carrillo and Professor Philip Scheltens, this workshop covered two themes selected based on their importance in the field: early detection and biomarkers; and advances in treatment. Speakers included Professor Oskar Hansson, Dr Cath Mummery, Dr Eric Siemers and Professor Reisa Sperling.
Friday 5 February 2021
Co-chaired by Professor Brian Lawlor and Paul Hogan, this workshop will cover progress made in the field of care and the challenges that remain, exploring models of care, the burden of caregivers, and art and music in dementia. Speakers include Professor Felicity Barker, Professor Louise Robinson, Professor Mary Sano and Dr Samir Sinha.
The world’s first G8 dementia summit was held in 2013 in London, where the international community of top scientists in the field, research funders, pharmaceutical companies and governments committed to accelerate the research agenda and deliver the first disease-modifying treatment by 2025. Since then the field has made considerable advances and there has been a significant increase in funding in the field of dementia research. This has been instrumental in fostering global collaborations and driving cutting-edge technological developments, including the use of big data, to understand the biology of dementia and develop potential therapeutics and treatments.
The prevention workshop will track progress made on reducing the risk of dementia, and will be led by Professor Kaarin Anstey, professor of psychology and director of the University of New South Wales Ageing Futures Institute, and Professor Philippe Amouyel, general director of Fondation Plan Alzheimer (France), professor of epidemiology and public health at the University Hospital of Lille, and a member of the World Dementia Council.
Tuesday 9 February 2021
07:00 GMT London | 08:00 CET Central Europe | 12:30 IST New Delhi | 16:00 JST Tokyo | 18:00 AEDT Sydney
Professor Kaarin Anstey
Kaarin Anstey is a professor of psychology and conducts public health research into dementia risk reduction ranging from analysis of cohort studies, development of risk assessment tools, and conducting risk reduction trials. Kaarin is the director of the University of New South Wales Ageing Futures Institute and is a conjoint senior principal research scientist at Neuroscience Research Australia. She chairs the International Research Network on Dementia Prevention and is a member of the governance committee of the Global Council on Brain Health, an initiative supported by AARP.
Professor Philippe Amouyel
Philippe Amouyel is general director of Fondation Alzheimer (France), professor of epidemiology and public health at the University Hospital of Lille, and a member of the World Dementia Council. Since 1998, he has headed a research unit of 110 people dedicated to public health and the molecular epidemiology of age-related diseases. He has published more than 850 scientific articles and participated in the discovery of 90% of the confirmed genetic loci predisposing to sporadic Alzheimer’s disease. At the European level, Philippe also chairs the European Joint Programming Initiative on Research on Neurodegenerative Diseases (JPND) and Alzheimer’s in particular. The main objective of JPND is to combine the strength of European and global research to tackle these diseases more efficiently.
Other events in the series
To inform the dementia landscape report, the Council is hosting two other virtual workshops for international dementia leaders focusing on key themes that were identified at the London dementia summit in 2013. In addition, the Council will host smaller roundtables that will focus on key themes and new policy priorities that we have agreed to highlight in the report. These themes include data sharing, technology in the health and social care sector, and the impact of dementia on low- and middle-income countries. See more below.